Regulations.gov document
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based…
Notice · FDA-2017-D-6146 · posted Jul 21, 2020
Key facts
| Document ID | FDA-2017-D-6146-0006 |
|---|---|
| Title | Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-6146 |
| Posted | Jul 21, 2020 |
| Federal Register citation | 85 FR 43989 |
| FR document number | 2020-15718 |
| CFR | 21 CFR Part 1271 |
| Comment period opens | Jul 21, 2020 |
| Effective date | Jul 21, 2020 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: